Bisphenol A, phthalates and lead and learning and behavioral problems in Canadian children 6-11 years of age: CHMS

Tye E Arbuckle1, Karelyn Davis1, Khrista Boylan2

  • 1Population Studies Division, Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa, ON, Canada.

Neurotoxicology
|March 30, 2016
PubMed

Insights

Environmental chemicals like BPA and phthalates may impact child behavior. This study found lead exposure, not BPA or phthalates, was most strongly linked to behavioral issues in children.

Area of Science:

  • Environmental Health
  • Pediatrics
  • Toxicology

Background:

  • Childhood developmental disorders, including learning disabilities and ADHD, pose significant burdens.
  • Environmental chemical exposures, such as bisphenol A (BPA) and phthalates, are suspected contributors to behavioral problems.

Purpose of the Study:

  • To investigate the association between urinary BPA and phthalate metabolite concentrations and child learning/behavioral problems.
  • To consider covariates like gender, blood lead, and environmental tobacco smoke (ETS) in the analysis.

Main Methods:

  • Utilized cross-sectional data from the Canadian Health Measures Survey (CHMS) Cycle 1.
  • Assessed outcomes using the Strengths and Difficulties Questionnaire (SDQ) and reported learning disabilities (ADD/ADHD).
  • Analyzed urinary BPA and phthalate metabolite concentrations alongside blood lead and ETS exposure.

Main Results:

  • Child urinary BPA was associated with psychotropic medication use (OR 1.59).
  • Urinary MBzP showed a significant association with emotional symptoms in girls (OR 1.38).
  • Blood lead was significantly linked to several adverse behavioral outcomes, with a notable interaction with prenatal smoking for the total difficulties score.

Conclusions:

  • While some associations were found between BPA/phthalates and child behavior, lead exposure emerged as the primary chemical linked to adverse behavioral indicators.
  • The cross-sectional design limits causal inference, but results highlight the significant impact of lead on child behavior.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
322
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
678
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
4.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
443
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
125